Evelo biosciences stock forecast
WebApr 12, 2024 · Evelo Biosciences Inc. (NASDAQ:EVLO)’s beta value is currently sitting at 1.25, while the Average True Range indicator is currently displaying 0.05. With analysts … WebAug 23, 2024 · Insiders who bought Evelo Biosciences, Inc. (NASDAQ:EVLO) stock lover the last 12 months are probably not as affected by last week’s 20% loss. After accounting for the recent loss, the...
Evelo biosciences stock forecast
Did you know?
WebMar 20, 2024 · Operator: Good morning and welcome to the Evelo Biosciences Conference Call to discuss its Fourth Quarter and Full Year 2024 Financial Results and Business Update. Please be advised this call is ... WebEvelo Biosciences, Inc. (EVLO) Q4 2024 Earnings Call Transcript 03/16/23-10:28AM EST Seeking Alpha Evelo Biosciences downgraded to Neutral from Overweight at Cantor …
WebSep 1, 2024 · Evelo Biosciences Inc - EVLO stock news - Page 2. Get the latest stock news for Nasdaq companies, press releases, financial disclosures and multimedia content, for day traders, investment community, individual investors and the general public. ... Evelo Biosciences is a clinical stage biotechnology company developing orally delivered … Web2 days ago · Evelo Biosciences - EVLO - Stock Price Today - Zacks Evelo Biosciences (EVLO) (Delayed Data from NSDQ) $0.26 USD -0.04 (-13.44%) Updated Mar 17, 2024 04:00 PM ET After-Market: $0.28 +0.02...
WebEvelo Biosciences price target lowered to $5 from $10 at BMO Capital March 17, 2024TipRanks Analysts Offer Insights on Healthcare Companies: Star Equity Holdings (STRR), Evelo Biosciences... WebOct 22, 2024 · Evelo Biosciences Market Cap: 237.58M, Enterprise value: N/A, P/E: -1.35, PEG ratio: 0.04, EPS: -2.13, Revenue: N/A, EBITDA: -116.01M, Income: -122.80M, Profit margin: 0%
WebFeb 20, 2024 · Evelo Biosciences Inc., which has a market valuation of $95.13 million, is expected to release its quarterly earnings report Mar 22, 2024 – Mar 27, 2024. Analysts tracking EVLO have forecast the quarterly EPS to shrink by -0.28 per share this quarter, while the same analysts predict the annual EPS to hit -$1.39 for the year 2024 and up to …
WebEvelo Biosciences, Inc. (EVLO) Q4 2024 Earnings Call Transcript 03/16/23-10:28AM EST Seeking Alpha Evelo Biosciences downgraded to Neutral from Overweight at Cantor Fitzgerald ratio\u0027s 2uWebBased on short-term price targets offered by four analysts, the average price target for Evelo Biosciences, Inc. comes to $2.45. The forecasts range from a low of $0.30 to a … ratio\u0027s 2yWebApr 3, 2024 · * Price Target & Stock Forecast ; Full Company Report ... Evelo Biosciences, Inc. has a VGM Score of C (this is a weighted average of the individual Style Scores which allow you to focus on the ... ratio\\u0027s 2vWebEvelo Biosciences Inc. is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 33 means that 67% of stocks … ratio\\u0027s 2xWebEvelo Biosciences Simple Moving Average . Analysis of Evelo Biosciences Simple Moving Average, A two period moving average forecast for Evelo Biosciences is based … ratio\u0027s 2xWebEvelo Biosciences Simple Moving Average . Analysis of Evelo Biosciences Simple Moving Average, A two period moving average forecast for Evelo Biosciences is based on an daily price series in which the stock price on... ratio\\u0027s 2zWebGet the latest Evelo Biosciences Inc (EVLO) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and … dr rod martinez